Laser Weapons Are Real Now and Changing Defense Stock Math
Directed-energy weapons have moved from sci-fi to battlefields, reshaping how investors look at defense plays like Palantir and Elbit.
If you grew up watching Star Wars and dreamed of laser cannons becoming real, well, here we are. Directed-energy weapons — basically high-powered lasers that can knock drones and missiles out of the sky — are no longer a Pentagon wish list item. They're being deployed, and that shift is turning some familiar names in the defense world into serious investor conversation pieces.
The counterdrone market is booming, and it's easy to see why. Traditional interceptor missiles can cost tens or even hundreds of thousands of dollars per shot. A laser beam, by contrast, costs next to nothing to fire once the system is built. That fundamental cost flip is what's getting Wall Street's attention, because it changes the long-term economics of air defense in a pretty dramatic way.
Read more Charter Stock Surges on Reported SpaceX Mobile Partnership →
Two names standing out in this space, according to MarketWatch, are Palantir and Elbit Systems. Palantir, which most people know as a data analytics and AI software company, has deep ties to defense and intelligence communities that position it well as militaries need smarter targeting and threat-detection systems. Elbit, an Israeli defense contractor, brings hardware and battlefield-tested technology to the table — a combination that looks compelling when global demand for counterdrone solutions is climbing fast.
For everyday investors, this is a good reminder that defense investing isn't just about tanks and aircraft carriers anymore. The next wave of military spending is increasingly software-driven, AI-powered, and focused on asymmetric threats like cheap commercial drones weaponized by bad actors. That opens doors for companies that might not fit the old-school defense contractor mold but are very much embedded in modern warfare.
If you want to dig deeper into the specific valuation cases and risk factors for these two stocks, Continue reading at MarketWatch.com.
